BMS-986454
- Generic Name
- BMS-986454
A Study to Evaluate the Safety, Tolerability and Drug Levels of BMS-986454 in Healthy Participants
- First Posted Date
- 2023-10-17
- Last Posted Date
- 2025-03-24
- Lead Sponsor
- Bristol-Myers Squibb
- Target Recruit Count
- 63
- Registration Number
- NCT06086886
- Locations
- 🇬🇧
Local Institution - 0001, Nottingham, United Kingdom
🇬🇧Local Institution - 0002, London, Greater London, United Kingdom
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath